Yes, Trintellix (vortioxetine) can be safely taken with lamotrigine, but requires careful monitoring for potential drug interactions.
The combination of Trintellix and lamotrigine is commonly used in clinical practice, particularly for patients with bipolar depression or treatment-resistant depression, though it requires awareness of a specific pharmacokinetic interaction.
Key Drug Interaction
Lamotrigine levels decrease significantly when combined with combined oral contraceptives (COCs), but this interaction does NOT apply to Trintellix. The evidence regarding lamotrigine interactions specifically addresses hormonal contraceptives 1, 2, not serotonergic antidepressants like vortioxetine. There is no documented contraindication or significant pharmacokinetic interaction between vortioxetine and lamotrigine.
Clinical Evidence Supporting Co-Administration
A naturalistic 24-week study specifically evaluated vortioxetine added to mood stabilizers in 60 patients with bipolar depression 3. Lamotrigine was one of the most frequently used concomitant mood stabilizers in this study, demonstrating:
- 73% response rate (44/60 patients)
- 52% remission rate (31/60 patients)
- Mean time to remission: 8.97 ± 4.05 weeks
- Only 6.7% discontinued due to adverse effects (nausea)
- 11.7% discontinued due to phase switch (mood destabilization)
- No significant safety concerns with the combination
The study found no significant associations between response/remission rates and the specific mood stabilizer used, including lamotrigine 3.
Safety Considerations
Serotonin Syndrome Risk
While Trintellix is a serotonergic agent, lamotrigine is NOT a serotonergic medication and does not contribute to serotonin syndrome risk 4. The FDA label for Trintellix lists serotonergic drugs that increase risk (triptans, SSRIs, SNRIs, tricyclics, tramadol, fentanyl, lithium, buspirone, St. John's Wort) but does NOT include lamotrigine or other anticonvulsants 4.
Mood Destabilization
Exercise caution regarding potential mood destabilization. Guidelines note that antidepressants may precipitate manic episodes in bipolar patients, though this risk is mitigated when combined with a mood stabilizer like lamotrigine 5. The naturalistic study showed an 11.7% phase switch rate, which is within acceptable ranges for antidepressant use in bipolar depression when combined with mood stabilization 3.
Bleeding Risk
Both medications can theoretically affect bleeding risk through different mechanisms. Monitor for bleeding if the patient is also taking NSAIDs, aspirin, or anticoagulants 4.
Practical Prescribing Approach
When combining Trintellix with lamotrigine:
Ensure lamotrigine is at a therapeutic dose for mood stabilization before adding vortioxetine
Start vortioxetine at 10 mg daily, which can be increased to 20 mg based on response 3
Monitor closely for:
- Mood destabilization or hypomanic/manic symptoms (especially first 8 weeks)
- Nausea (most common side effect, typically resolves)
- Bleeding events if on anticoagulants
- Suicidal ideation (particularly in patients under 25 years) 4
Assess response at 8-12 weeks - this is the appropriate timeframe for evaluating effectiveness 3, 6
Common Pitfalls to Avoid
- Do not assume all anticonvulsants interact similarly. The lamotrigine-COC interaction does NOT extend to vortioxetine 1, 2
- Do not use vortioxetine as monotherapy in bipolar depression - always maintain mood stabilization with lamotrigine or another appropriate agent 5, 3
- Do not discontinue either medication abruptly - both require gradual tapering to avoid withdrawal symptoms 4
This combination has demonstrated efficacy and tolerability in real-world clinical practice for bipolar depression, with the primary monitoring focus being mood stability rather than drug-drug interactions 3.